title: [Development mechanisms and prognostic value of myocardial ischemia].
abstract: Silent myocardial ischemia (SMI) is a poor prognostic sign of cardiac events development, such as myocardial infarction and sudden cardiac death. This article presents the last decade research findings dedicated exploring mechanisms of SMI development and prognostic value in patients with coronary heart disease.
authors.forename: V H
authors.initials: VH
authors.lastname: Lyzogub
authors.forename: T V
authors.initials: TV
authors.lastname: Zaval's'ka
authors.forename: L A
authors.initials: LA
authors.lastname: Stakhurs'ka
authors.forename: D A
authors.initials: DA
authors.lastname: Pliskevych
authors.forename: O V
authors.initials: OV
authors.lastname: Savchenko
mesh_terms: D058070:Asymptomatic Diseases; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000473:pathology*; D018450:Disease Progression; D004562:Electrocardiography; D005260:Female; D005728:Ganglia, Sympathetic / Q000378:metabolism / Q000473:pathology*; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000473:pathology*; D017202:Myocardial Ischemia / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000473:pathology*; D059225:Nociception / Q000502:physiology; D018847:Opioid Peptides / Q000378:metabolism; D018047:Receptors, Purinergic P1 / Q000378:metabolism; D012307:Risk Factors
chemical_list: D018847:Opioid Peptides; D018047:Receptors, Purinergic P1